DMA provides Audit Management & Defense services for the Medical Device Excise Tax, which is imposed on the sale or importation of FDA-listed medical devices absent exemption. DMA provides the following: 

Preliminary Audit Review

Before the IRS begins its audit, it is prudent to review your current systems and processes for capturing Medical Device Excise Tax due and/or exemptions. DMA performs a comprehensive review to identify taxable transactions ensuring you have no surprises, apply proper sales pricing since the tax base is computed as the wholesale price less deductions plus other add backs, and apply exemptions to permit the proper tax deduction to be reported. 

Audit Management

DMA manages the entire audit process, taking proactive positions on potential savings opportunities and limiting the audit to current issues. 

Position Defense

DMA’s experienced tax professionals advocate positions on any issues arising that might unfavorably impact the audit. 

Post-Audit Implementation

DMA works with you to apply the audit findings with a focus on minimizing future liabilities.